[Experimental study on chemotherapeutic efficacy, acute toxic action and nephrotoxicity of combinations of eremomycin with tobramycin].
Chemotherapeutic efficacy of eremomycin in combination with tobramycin was investigated on a model of experimental sepsis of albino mice caused by Staphylococcus aureus cultures resistant to methicillin. Eremomycin is a novel original antibiotic of the glycopeptide structure isolated in the USSR and tobramycin is an aminoglycoside. Acute toxicity of the combination with a wide range of the dose fixed proportions was studied on mice and the nephrotoxic action of the antibiotics and their combinations administered intravenously for 5 days was studied on albino rats. The experiments showed that the chemotherapeutic effect of eremomycin in combination with tobramycin was of synergistic nature. Acute toxicity of the combined drugs mainly summed up and somewhat increased when the proportion of tobramycin and eremomycin was 1:2.4 or 1:3.6. Eremomycin had a dose-depended nephrotoxicity. Summing up of the nephrotoxic action of the drugs on their combined use was observed.
Shepelevtseva
N G
NG
Vinogradova
I V
IV
Shevniuk
L A
LA
D000818:Animals; D000900:Anti-Bacterial Agents; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000627:therapeutic use / Q000633:toxicity; D006020:Glycopeptides / Q000627:therapeutic use / Q000633:toxicity; D007674:Kidney Diseases / Q000139:chemically induced*; D051379:Mice; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014031:Tobramycin / Q000627:therapeutic use* / Q000633:toxicity
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; C053759:eremomycin; D014031:Tobramycin
Eksperimental'noe izuchenie khimioterapevticheskoĭ éffektivnosti, ostrogo toksicheskogo deĭstviia i nefrotoksichnosti kombinatsii éremomitsina s tobramitsinom.